Literature DB >> 22122868

Fish oil attenuates surgery-induced immunosuppression, limits post-operative metastatic dissemination and increases long-term recurrence-free survival in rodents inoculated with cancer cells.

Yael Goldfarb1, Haim Shapiro, Pierre Singer, Yael Kalderon, Ben Levi, Ariella Glasner, Marganit Benish, Shamgar Ben-Eliyahu.   

Abstract

BACKGROUND & AIMS: Omega-3 fatty acids (ω-3FA) attenuate postoperative immunosuppression vis-à-vis infection. Since immune-surveillance targets metastasizing cancer cells, we assessed the effect of ω-3FA consumption on 1) early post-operative Natural Killer cell (NK) cytotoxicity and metastases and 2) long-term recurrence-free survival, in two rodent models of surgery-promoted metastases.
METHODS: C57BL/6J mice were fed standard, ω-3FA-enriched, or ω-6FA-enriched chow, beginning one week before subcutaneous footpad implantation of syngeneic melanoma cells. When tumors reached the volume of 110 μl, the tumor-bearing footpad was amputated, and long-term recurrence-free survival was assessed. Also, F344 rats were fed ω-3FA or ω-6FA for a month before undergoing or not undergoing laparotomy, and were intravenously inoculated with radio-labeled syngeneic adenocarcinoma cells. Marginating-pulmonary (MP)-leukocytes were harvested, and lung tumor retention (LTR) of metastases was assessed.
RESULTS: ω-3FA consumption did not affect the growth of footpad tumors, but significantly enhanced post-amputation recurrence-free survival in mice. Surgery had a deleterious effect on NK cell activity and LTR whereas ω-3FA had large beneficial effects in non-operated rats and an even greater impact in operated rats.
CONCLUSIONS: ω-3FA feeding attenuates or even overcomes postoperative NK cell suppression, increases resistance to experimental and spontaneous metastasis, and enhances recurrence-free survival following excision of metastasizing primary tumors. These findings warrant clinical studies of ω-3FA-based nutrition in patients undergoing resection of a primary tumor.
Copyright © 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22122868     DOI: 10.1016/j.clnu.2011.10.015

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  4 in total

Review 1.  Exploiting the critical perioperative period to improve long-term cancer outcomes.

Authors:  Maya Horowitz; Elad Neeman; Eran Sharon; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2015-01-20       Impact factor: 66.675

Review 2.  Regulating surgical oncotaxis to improve the outcomes in cancer patients.

Authors:  Toshihiro Hirai; Hideo Matsumoto; Hisako Kubota; Yoshiyuki Yamaguchi
Journal:  Surg Today       Date:  2013-06-05       Impact factor: 2.549

3.  High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.

Authors:  Xiao-Yan Duan; Qin Pan; Shi-Yan Yan; Wen-Jin Ding; Jian-Gao Fan; Liang Qiao
Journal:  BMC Gastroenterol       Date:  2014-11-20       Impact factor: 3.067

Review 4.  Tumor Excision as a Metastatic Russian Roulette: Perioperative Interventions to Improve Long-Term Survival of Cancer Patients.

Authors:  Shamgar Ben-Eliyahu
Journal:  Trends Cancer       Date:  2020-07-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.